Regulators in Missouri are recalling thousands of cannabis products

The Missouri Division of Cannabis Regulation stated that it is “issuing a patient and consumer notice to alert patients and consumers of a mandatory product recall” affecting “manufactured products manufactured by infusion product manufacturer, Delta Extraction, LLC, MAN000022 , sold to pharmacies and manufacturers.”

According to the agency, the “recalled products were not properly tracked in the nationwide Track and Trace (METRC) system.” [Division of Cannabis Regulation] to verify that the products are derived from marijuana grown in Missouri or that the product has passed the required tests before being sold in dispensaries.”

Monday’s statement said that “no side effects have been reported for this product.” [Division of Cannabis Regulation] “At this time,” the agency says, all patients and consumers “who purchased the recalled product should discontinue use.”

“All unused products should be discarded or returned to the pharmacy where they were purchased. Returned products do not count towards a patient’s purchase limit. For more information on returns, please contact the pharmacy where the product was purchased.”

For a complete list of the 62,800 total cannabis products recalled, visit the Missouri Department of Health and Human Services website.

Sales of medicinal cannabis began in Missouri in October 2020, while sales of adult-use cannabis began in February.

In May, the state reported that cumulative cannabis sales for both medical and adult use surpassed $1 billion.

“Missouri’s newest multi-billion dollar industry is seeing significant job growth, providing great products and services to Missouri residents, and is becoming an integral part of the local economy across the state,” said Andrew Mullins, executive director of the Missouri Cannabis Trade Association, after the numbers were reported. “Missouri avoided so many of the initial problems experienced by other states in transitioning from a medical cannabis program focused on quality, affordability, access and choice. Missouri’s cannabis program couldn’t have gotten off to a better start. A sincere thank you to all of the patients, customers and small business owners who helped Missouri reach this impressive milestone.”

In the first month of the Missouri adult recreational cannabis market, sales exceeded $100 million.

Mullins noted at the time that the number was “more than double that of Illinois in a state with twice the population.”

“So it really shows the interest and enthusiasm for the new adult consumption industry in Missouri,” Mullins said earlier this year.

“Canna tourists who may choose to come to Missouri to access and use cannabis,” he added. “It also appears to be affecting sales in Missouri.”

Still, product recalls are a fact of life in any legal cannabis market – and a reminder of the importance of sound and thorough regulation.

Regulators in Colorado last year issued a recall after finding “potentially unsafe levels of total yeast, mold and Aspergillus on medical marijuana buds (budding/shaking/trimming)”.

The Colorado Department of Revenue (DOR) and Colorado Department of Public Health and Environment issued a recommendation in the fall that said, “They consider it a public health and safety hazard if marijuana is found to be intoxicating a person.” Total Yeasts, Molds and Aspergillus.” meets the established acceptable limits.”

“[The Department of Revenue] has identified batches of medical marijuana crops manufactured by [The Living Rose] not submitted for testing … medical marijuana harvest batches manufactured by [The Living Rose] had to be checked by the [Department of Revenue] and were found to contain overall more yeast, mold and Aspergillus than acceptable levels,” the statement said.